Prediction of Rituximab Hypersensitivity and Desensitization Treatment
NCT04610242
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Drug Hypersensitivity Reaction
Interventions
DIAGNOSTIC_TEST:
skin test
Sponsor
Peking Union Medical College Hospital